Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

Interactive: Best Behaviour

Download our curated collection of case studies and other useful resources that illustrate how we apply the principles of behavioural science in our research design.

Inizio

- PMLiVE

Measurement in Med Comms: Striving for Creative Effectiveness

How to achieve creative success in Med Comms (Article written 6th Jan 2020)

Dice Medical Communications

A person smiling for the cameraDescription automatically generated with medium confidence

Reflections on the MAPS EMEA 2022 Annual Meeting

Amanda Henkel, VP Strategy, Nucleus X Consulting (part of Nucleus Global) shares her thoughts on this year’s meeting.

Nucleus Global

- PMLiVE

Genentech’s Evrysdi gets extended FDA approval for spinal muscular atrophy

The drug is now approved to treat SMA in children and adults of all ages

- PMLiVE

Sandoz launches ‘Act4Biosimilars’ initiative to address global health inequalities

The initiative wants to increase the global use of biosimilars by at least 30% by 2030

- PMLiVE

Leipzig/Halle Airport region in Germany joins forces to attract investors

The airport and development agencies sign an extensive cooperation agreement

Relaunch post

Fox&Cat Now Helps All Communications Teams To Thrive Under Pressure

Specialist communications agency fox&cat relaunches today with a refined proposition: to help all communications teams thrive under pressure.  So, whether pressure is being felt in an in-house team, an agency, or...

Fox&Cat

- PMLiVE

Novartis’ Kymriah receives FDA approval to treat follicular lymphoma

The CAR-T cell treatment is approved for adult patients who have had two or more previous therapies

- PMLiVE

NRG Therapeutics receives £2.68m Innovate UK Award

The funds will be used for research into new treatments for Parkinson’s and motor neurone disease

- PMLiVE

Diversity in Pharma: The Impact of COVID-19 on DE&I

COVID-19 has had a huge impact on how we all think and act. Our working environments may look very different now to the way they did pre-pandemic, and not all...

- PMLiVE

Phase 3 trial initiated to evaluate AZ’s Saphnelo in lupus nephritis

The antibody has already been approved to treat systemic lupus erythematosus

- PMLiVE

Dermavant’s Vtama receives FDA approval for plaque psoriasis

It is the first topical steroid-free cream to be granted FDA approval in its class

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links